BenevolentAI to power small molecule drug discovery BenevolentAI has entered a two-year agreement with the MRC Technology to investigate new small molecule and antibody drug candidates.

Single-molecule fluorescence experiments involve the study of individual fluorescent molecules, and can provide information that would be hidden in measurements involving a large number of molecules.

Single-molecule biophysics articles from across Nature Portfolio Single-molecule biophysics is the study of the dynamics and interactions of individual biomolecules to understand how they carry ...

Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million ...